Abstract
A summary is presented of four case studies of extensive disease small-cell lung cancer patients with initial symptomatic brain metastases, who were initially successfully treated with concurrent chemoradiotherapy of the neurocranium followed by consolidation chemotherapy and thoracic chemoradiotherapy, but shortly after the initial treatment developed a sequence of central nervous system relapses despite second-line therapy. Symptoms of the effect on the central nervous system dominated the course of the cancer disease, whereas the primary tumor mass remained in complete remission in all four patients until the end of the follow-up period.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Seute T, Leffers P, ten Velde GPM et al (2004) Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 100:801–806
Hochstenbag MMH, Twijnstra A, Wilmink JT (2000) Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 48:243–248
Manapov F, Klautke G, Fietkau R (2008) Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thorac Oncol 3(6):652–655
Nugent JL, Bunn PA Jr, Matthews MJ et al (1979) CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44:1885–1893
Seute T, Leffers P, ten Velde GPM et al (2008) Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer 112(8):1827–1834
Postmus P, Smit E (1999) Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 10:753–759
Mira JG, Chen TT, Livingston RB et al (1988) Outcome of prophylactic and therapeutic cranial irradiation in disseminated small cell lung carcinoma: a Southwest Oncology Group Study. Int J Radiat Oncol Biol Phys 14(5):861–865
Lee JS, Murphy WK, Glisson BS et al (1989) Primary chemotherapy of brain metastases in small cell lung cancer. J Clin Oncol 7:916–922
Hoskin PJ, Brada M (2001) Radiotherapy for brain metastases. Clin Oncol 13:91–94
Reboul F, Vincent P, Brewer Y, Faure CF, Taulelle M (1996) Chemoradiotherapy for brain metastases of lung origin. Results of a phase II study. ASCO Annual Meeting 1996; Abstract No: 1106
Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M (2000) Concurrent chemoradiotherapy with cisplatin-etoposide for patients with brain metastases from lung cancer: results at four years. Proc Am Soc Clin Oncol 19:2000 (abstr 1965)
Postmus PE, Haaxma-Reiche H, Smit EF et al (2000) Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy—a Phase III Study of the European Organization fort he Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18(19):3400–3408
Kouvaris JR, Miliadou A, Kouloulias VE et al (2007) Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30(7):361–366
Giannone L, Johnson DH, hande KR et al (1987) Favorable prognosis of brain metastases in small cell lung cancer. Ann Intern Med 106(3):386–389
Kochhar R, Frytak S, Shaw EG (1997) Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis. Am J Clin Oncol 20(2):125–127
Videtic GM, Adelstein DJ, Mekhail TM et al (2007) Validation of the RTOG recursive partitioning analysis (RPA) classification for small cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 1(67):240–243
Seute T, Leffers P, Wilmink JT et al (2006) Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol 24(13):2079–2082
Yue X, Zang OC (2004) Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases. Ai Zheng 23(12):1671–1676
Korfel A, Oehm C, von Pawel J et al (2002) Response to topotecan of symptomatic brain metastases of small cell lung cancer also after whole-brain irradiation: a multicentre phase II study. Eur J Cancer 38(13):1724–1729
Postmus PE, Haaxma-Reiche H, Gregor A et al (1998) Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 46(1):29–32
Hoskin PJ, Yarnold JR, Smith IE et al (1986) CNS relapse despite prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys 12(11):2025–2028
Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: prophylactic cranial irradiation overview collaborative group. N Engl J Med 341:476–484
Abrey LE, Olson JD, Raizer JJ et al (2001) A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 53:259–265
Omuro AM, Raizer JJ, Demopoulos A et al (2006) Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial. J Neurooncol 78:277–280
Serizawa T, Ono J, Iichi T et al (2002) Gamma knife radiosurgery fro metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma. J Neurosurg 97:484–488
Sheehan J, Kondziolka D, Flickinger J et al (2005) Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 102:247–254
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manapov, F. Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy. J Neurooncol 98, 349–355 (2010). https://doi.org/10.1007/s11060-009-0079-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-009-0079-y